维普中文期刊产品整合服务
6篇 您的检索式:作者名="David Posada"
    题名 作者 年代 出处 被引量
1Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine显示文摘AIM To compare the impact of tacrolimus(FK) and cyclosporine(CYA) on acute rejection and graft survival and to assess the predominant causes of graft loss between patients receiving these two calcineurin inhibitors(CNIs).METHODS Retrospective review of 1835 patients who received a kidney transplant(KTX) between 1999-2012. Patients were grouped based on initial CNI utilized: 1195 in FK group, 640 in CYA group. Data on baseline characteristics, clinical outcomes, and causes of graft loss in both groups were analyzed. RESULTS Cumulative acute rejection rates were 14% in the FK vs 24% in the CYA group. Despite more marginal donor characteristics in the FK group, these patients had better graft survival rates compared to the CYA group. Three and five year graft survival rates were 88% and 84% respectively in the FK group compared to 79% and 70% respectively in the CYA group(P < 0.001). After multivariate analysis, which controlled for confounders, FK use was a strong predictor for lower acute rejectionrates [odds ratio(OR) 0.60, 95%CI: 0.45-0.79] and better renal allograft survival(OR 0.740, 95%CI: 0.58-0.94). Death with a functioning graft was the most common cause of graft loss in both groups. Common causes of death included cardiovascular disease, infections, and malignancies. Chronic allograft nephropathy was also found to be an important cause of graft loss, being more prevalent in the CYA group. CONCLUSION The use of FK-based maintenance immunosuppression therapy is associated with a significantly lower rate of acute rejection and better graft survival compared to CYA-based regimen. Individualizing immunosuppression through risk-stratified CNI choice may lead to improved outcomes across all spectra of KTX patients.Mahmoud Kamel Manish Kadian Titte Srinivas David Taber Maria Aurora Posadas Salas 2016World Journal of Transplantation2016,6,4:2
2Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy显示文摘Antonio Carvajal-Rodríguez Keith A. Crandall David Posada 2007Infection Genetics and Evolution2007,,4:1
3Automated Phylogenetic Detection of Recombination Using a Genetic Algorithm显示文摘Sergei L Kosakovsky Pond David Posada Michael B Gravenor 2006Mol Biol Evol2006,23,10:1
4Intraspecific gene genealogies: trees grafting into networks显示文摘David Posada Keith A. Crandall 2000Trends in Ecology & Evolution2000,,1:1
5Intraspecific gene genealogies: trees grafting into networks显示文摘David Posada Keith A. Crandall 2000Trends in Ecology & Evolution2000,,:1
6他汀降脂治疗的药物遗传学研究显示文摘背景:胆固醇合成、吸收和转运相关基因的多态性也许会影响他汀的疗效。Daniel I. Chasman David Posada Lakshman Subrahmanyan 崔艳丽(译) 赵秀丽(校) 2005美国医学会杂志(中文版)2005,24,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费